Dermatological adverse events in Chinese prostate cancer patients treated with the androgen receptor inhibitor apalutamide
Apalutamide-associated dAEs are common in the Chinese population, among which the majority are mild to moderate, with pruritus, erythema, and papules ranking as the most prevalent symptoms. Elevated PSA levels were documented in patients with dAEs.
Authors
- Haochen Gu (ORCID: https://orcid.org/0009-0005-8811-8736)
- Zhuangli Tang (ORCID: https://orcid.org/0000-0001-8390-079X)
- Qi Wang (ORCID: https://orcid.org/0000-0002-6327-0468)
- Huifeng Wu (ORCID: https://orcid.org/0000-0002-4042-8103)
- Xia-Wei Li
- Zhao-Ting Ren
Institutions
- Taixing People's Hospital (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-02-20
- DOI
- https://doi.org/10.3389/fimmu.2025.1530919
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Medical Science and Technology Project of Zhejiang Province
- Natural Science Foundation of Zhejiang Province